Poster Session Presenters | AIChE

Poster Session Presenters





Poster # Abstract Title First Name Last Name Affiliation
1 A Novel One-Step Method for Targeted Multiplication of DNA Fragments in Escherichia coli chromosome Olga Igonina Ajinomoto-Genetika Research Institute
2 Optimization and Modeling of Crrna Design for Pathogen Detection By Cas13 Enzymes Zachary Schultzhaus National Research Council
3 Harnessing Endogenous Repair Mechanisms for Precise Modification of in Vitrofertilized Bovine Embryos Joseph Owen University of California, Davis
4 In Vivo analysis of CAS1/2-CAS3 Proteins Interaction during Primed Adaptation Olga Musharova Skolkovo Institute of Science and Technology, Institute of Molecular Genetics, Russian Academy of Sciences
5 Generation and Validation of Human Pluripotent Stem Cell Disease Models Using CRISPR/Cas9 Genome Engineering Soeren Turan Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany (FAU), Department of Stem Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
6 Adaptation By T. Thermophilus Type III CRISPR-Cas System in the Presence of Different Phages and Appearance of Viral Escapes Daria Artamonova Skolkovo Institute of Science and Technology
7 Evaluation of CRISPR Spacers Diversity in Clostridium Difficile Clinical Isolates Polina Muzyukina Skolkovo Institute of Science and Technology, Skolkovo
8 Outcomes of Genome Targeting in Bacteria Vary between CRISPR Nucleases Elena Vialetto Helmholtz Institute for RNA-based Infection Research
9 Analysis of Spacers Precursors in Cells Undergoing Naive Adaptation Noemi M. Guzmán Skoltech, University of Alicante
10 Specificity of Prespacer Choice during CRISPR Adaptation Danylo Vyhovskyi Skolkovo Institute of Science and Technology
11 CRISPR Array Reconstruction Shields Light on Diversity and Dynamics of Escherichia coli Populations Ekaterina Savitskaya Institute of Molecular Genetics, Russian Academy of Sciences
12 Possible Targets for Heterochromatin to Euchromatin Transition of Genes Using CRISPR/dCas9-Mediated Epigenome Editing Kamyar Keshavarz Farajkhah Shahid Beheshti University of Medical Sciences, School of Pharmacy, Tehran, Iran
13 Extensive Self-Targeting By CRISPR-Cas Systems in the Plant Pathogen Xanthomonas Albilineans Franziska Wimmer Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Centre for Infection Research (HZI), 97080 Würzburg, Germany
14 Modular, One-Pot Assembly of CRISPR Arrays Enables Library Generation, Multi-Nuclease Targeting and Reveals Factors Influencing CRISPR RNA Biogenesis Chunyu Liao Helmholtz Institute for RNA-based Infection Research
15 A Cas12a-Mediated Crispri Screen for Small Noncoding RNAs in the Human Commensal Bacteroides Thetaiotaomicron Gianluca Prezza Helmholtz Institute for RNA-based Infection Research
16 Binding Does Not Equal Function: Linking Glucocorticoid Receptor Binding to the Regulation of Genes in the Endogenous Genomic Context Sebastiaan Meijsing Max Planck Unit for the Science of pathogens, Max Planck Institute for Molecular Genetics
17 Co-Expressing the S. Pyogenes Cas9 and Its Tracrrna Induces Potent, Strain-Specific Cytotoxicity in Lactobacilli Justin Vento North Carolina State University
18 Endogenous Tagging Strategies for Accelerated Target Validation and Detection Giovanni Ciotta AstraZeneca
19 CRISPR/Cas9 meets recombineering in P. putida KT2440 Tomás Aparicio Centro Nacional de Biotecnología (CNB-CSIC)
20 Cas9-Based Strategies to Rescue Deep-Intronic Mutations in ABCA4 Pietro De Angeli University of Tübingen
21 CRISPR/Cas9-Mediated Regulation of GAS5-Encoded Box-C/D Small Nucleolar RNAs Anastasiya Matveeva Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk State University
22 Detection of Recbcd-Generated DNA Products in Escherichia coli Cells Undergoing CRISPR Interference Anna Shiriaeva Skolkovo Institute of Science and Technology
23 CRISPR-Cas9 Mediated Knockout of Host Restriction Factors Allows Increasing Influenza A Virus Replication in Human Cell Line Stepanov Grigory Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk State University
24 Precision gene-engineering meets cancer immunotherapy: Targeted insertion of chimeric antigen receptors into the T-cell genome using a novel, virus-free CRISPR/Cas9 knock-in strategy Justus Weber Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II
25 Natural Diversity of CRISPR Spacers Sofia Medvedeva Skoltech
26 The Impact of Cellular Genome Maintenance Proteins on Primed CRISPR Adaptation By the Escherichia coli Type I-E CRISPR-Cas System Elena Kurilovich Skolkovo Institute of Science and Technology
27 DNA Mimic Protein Ocr from Phage T7 Is a Potent Inhibitor of Brex Defence System Artem Isaev Skolkovo Institute of Science and Technology
28 Establishing a CRISPR/Cas9 Based System Designed to Explore the Similarities and Differences between Lysyl Oxidases Inbal Nir Zvi Technion
29 Direct Targeting the Expanded CAG Repeat in Huntington's Diseases Using CRISPR/Cas9 Dooeun Choi Massachusetts General Hospital/ Harvard Medical School
30 Genome Editing for FVIII and AAT Gene Therapy Cures Reka Lorincz Washington University in St Louis
31 Utilizing CRISPR/Cas Technology for Point-of-Care Diagnosis Oskar Franch Delft University of Technology
32 SuCms1 is a type V CRISPR nuclease variant with a broad PAM preference and tolerance to anti-CRISPR proteins Oleg Dmytrenko Helmholtz Institute for RNA-based Infection Research
33 Head-to-Tail Multiplications of DNA Templates at Sites of Integration Mask Desired CRISPR/Cas9 - Mediated Genome Editing Events Boris Skryabin Core Facility Transgenic animal and genetic engineering Models (TRAM)
34 CRISPR/Cas12a multiplex genome editing and transcriptional regulation in S. cerevisiae Klaudia Ciurkot DSM Biotechnology Center, Delft, the Netherlands